Biocon Secures USFDA Nod for Generic Liraglutide Prefilled Pens for Diabetes
New Delhi: Biocon Limited's wholly owned subsidiary Biocon Pharma Limited has received approval from the U.S. Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Liraglutide…